Pediatrix Medical Group (NYSE:MD) Announces Quarterly Earnings Results, Beats Expectations By $0.07 EPS

Pediatrix Medical Group (NYSE:MD) posted its quarterly earnings data on Friday. The company reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.07, Briefing.com reports. Pediatrix Medical Group had a positive return on equity of 10.59% and a negative net margin of 12.58%. The company had revenue of $511.20 million for the quarter, compared to analysts’ expectations of $498.87 million. During the same period in the previous year, the firm posted $0.29 EPS. Pediatrix Medical Group’s revenue was up .9% compared to the same quarter last year.

Pediatrix Medical Group Trading Up 23.5 %

MD traded up $2.89 during trading hours on Friday, reaching $15.21. The company’s stock had a trading volume of 3,254,058 shares, compared to its average volume of 871,407. The stock has a market cap of $1.31 billion, a PE ratio of -5.02, a P/E/G ratio of 1.96 and a beta of 1.56. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.38 and a quick ratio of 1.38. Pediatrix Medical Group has a fifty-two week low of $6.62 and a fifty-two week high of $15.42. The business’s 50-day moving average is $11.54 and its 200-day moving average is $9.36.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on MD. StockNews.com upgraded Pediatrix Medical Group from a “sell” rating to a “hold” rating in a report on Wednesday, August 7th. Truist Financial boosted their target price on Pediatrix Medical Group from $10.00 to $13.00 and gave the stock a “hold” rating in a report on Monday, October 7th. UBS Group boosted their target price on Pediatrix Medical Group from $9.00 to $10.50 and gave the stock a “neutral” rating in a report on Friday, August 9th. Finally, Jefferies Financial Group upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating and upped their price objective for the company from $8.00 to $14.00 in a report on Thursday, September 26th. Five equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $10.90.

Insider Buying and Selling at Pediatrix Medical Group

In other Pediatrix Medical Group news, CFO C Marc Richards sold 32,562 shares of the business’s stock in a transaction that occurred on Friday, August 9th. The stock was sold at an average price of $10.08, for a total value of $328,224.96. Following the sale, the chief financial officer now owns 192,785 shares of the company’s stock, valued at $1,943,272.80. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other news, CFO C Marc Richards sold 32,562 shares of the company’s stock in a transaction on Friday, August 9th. The stock was sold at an average price of $10.08, for a total transaction of $328,224.96. Following the sale, the chief financial officer now owns 192,785 shares of the company’s stock, valued at approximately $1,943,272.80. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO James D. Swift sold 11,100 shares of the company’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $10.79, for a total value of $119,769.00. Following the sale, the chief executive officer now directly owns 170,001 shares in the company, valued at $1,834,310.79. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 68,100 shares of company stock valued at $701,889 over the last quarter. 2.00% of the stock is owned by company insiders.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.